Peginterferon still has a place in the treatment of hepatitis C caused by genotype 3 virus (2017)
- Authors:
- USP affiliated authors: CORRÊA, MARIA CASSIA JACINTHO MENDES - FM ; MARTINELLI, ANA DE LOURDES CANDOLO - FMRP
- Unidades: FM; FMRP
- DOI: 10.1590/S1678-9946201759067
- Subjects: HEPATITE C; GENÓTIPOS
- Language: Inglês
- Imprenta:
- Source:
- Título: Revista do Instituto de Medicina Tropical de Sao Paulo
- ISSN: 0036-4665
- Volume/Número/Paginação/Ano: v. 59, article ID UNSP e67, 8p, 2017
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
GRANDO, Aline Vitali e MARTINELLI, Ana de Lourdes Candolo e CORREA, Maria Cássia Jacintho Mendes. Peginterferon still has a place in the treatment of hepatitis C caused by genotype 3 virus. Revista do Instituto de Medicina Tropical de Sao Paulo, v. 59, 2017Tradução . . Disponível em: https://doi.org/10.1590/S1678-9946201759067. Acesso em: 13 fev. 2026. -
APA
Grando, A. V., Martinelli, A. de L. C., & Correa, M. C. J. M. (2017). Peginterferon still has a place in the treatment of hepatitis C caused by genotype 3 virus. Revista do Instituto de Medicina Tropical de Sao Paulo, 59. doi:10.1590/S1678-9946201759067 -
NLM
Grando AV, Martinelli A de LC, Correa MCJM. Peginterferon still has a place in the treatment of hepatitis C caused by genotype 3 virus [Internet]. Revista do Instituto de Medicina Tropical de Sao Paulo. 2017 ; 59[citado 2026 fev. 13 ] Available from: https://doi.org/10.1590/S1678-9946201759067 -
Vancouver
Grando AV, Martinelli A de LC, Correa MCJM. Peginterferon still has a place in the treatment of hepatitis C caused by genotype 3 virus [Internet]. Revista do Instituto de Medicina Tropical de Sao Paulo. 2017 ; 59[citado 2026 fev. 13 ] Available from: https://doi.org/10.1590/S1678-9946201759067 - Preliminary results from TOPAZ-III, a phase 3b study evaluating the efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir ± ribavirin in naive or experienced adults in Brazil with HCV genotype 1 infection and advanced fibrosis/cirrhosis
- The clinical effectiveness of pegylated interferon and ribavirin for the treatment of chronic hepatitis C in HIV-infected patients in Brazil: a multicentric study
- Noninvasive models for predicting liver fibrosis in individuals with hepatitis D virus/hepatitis B virus coinfection in the brazilian amazon region
- Evaluation of the utilization of filmArray meningitis/encephalitis in children with suspected central nervous system infection a retrospective case series
- Extended treatment with pegylated interferon alfa/ribavirin in patients with genotype 2/3 chronic hepatitis C who do not achieve a rapid virological response: final analysis of the randomised N-CORE trial
- How are HCV-infected patients being identified in Brazil: a multicenter study
- Hepatitis B: prevalence and occult infection in HIV-infected patients
- Hepatitis C disease burden and strategies for elimination by 2030 in Brazil.: a mathematical modeling approach
- Contribuição para o estudo das hepatites B e C em pacientes co-infectados pelo vírus da imunodeficiência humana
- Disease burden of chronic hepatitis C in Brazil
Informações sobre o DOI: 10.1590/S1678-9946201759067 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
